Floatz logo

Letrozole

Overall Survival

Jagiellonian UniversitySmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Overall Survival cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
Peking University First Hospital
Phase 4BB
SUFENTANYL
Peking University First Hospital
Phase 4BB
FILGRASTIM
Hospital General de Mexico
Phase 3B
Mebendazole
Health Clinics Limited
Phase 3B
Doxycycline
Health Clinics Limited
Phase 3B
Azacitidine
Sun Yat-sen University
N/AD
Tucidinostat
Sun Yat-sen University
N/AD
mln9708
RenJi Hospital
N/AD

Same molecule, other indications

Letrozole is also rated in:

infertility disorderDormant
BBB
Indicative ·
79 / 100
View asset →
anovulationDormant
BBB
Indicative ·
78 / 100
View asset →
Diabetes MellitusDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →